Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.trecan.2017.05.004 http://scihub22266oqcxt.onion/10.1016/j.trecan.2017.05.004 C5646417!5646417 !28718401     free     free     free       Trends+Cancer 2017 ; 3 (7 ): 471-474 Nephropedia Template TP {{tp|p=28718401 |t=2017. Targeting ATF5 in Cancer |pdf=|usr=}}{{28718401 }} gab.com Text Targeting ATF5 in Cancer JO: Trends Cancer http://www.kidney.de/pget.php?&tw=1&pmid=28718401 #FOAvip The expression of activating transcription factor 5 (ATF5) correlates negatively with patient survival in different types of cancer. ATF5 is important for the survival and proliferation of cancer cells, and can be targeted to selectively trigger cancer cell apoptosis while sparing normal cells. Cell-penetrating peptides combined with a dominant negative ATF5 cargo have recently shown efficacy against brain, breast, melanoma, and prostate cancers. Twit Text FOAVip Targeting ATF5 in Cancer ????Trends Cancer http://www.kidney.de/pget.php?&tw=1&pmid=28718401 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28718401 #FOAvip English Wikipedia <ref>{{Cite pmid|28718401 }}</ref> Targeting ATF5 in Cancer #MMPMID28718401 Angelastro JM Trends Cancer 2017[Jul]; 3 (7 ): 471-474 PMID28718401 show ga The expression of activating transcription factor 5 (ATF5) correlates negatively with patient survival in different types of cancer. ATF5 is important for the survival and proliferation of cancer cells, and can be targeted to selectively trigger cancer cell apoptosis while sparing normal cells. Cell-penetrating peptides combined with a dominant negative ATF5 cargo have recently shown efficacy against brain, breast, melanoma, and prostate cancers. |Activating Transcription Factors/*antagonists & inhibitors/genetics/metabolism [MESH] |Animals [MESH] |Antineoplastic Agents/*pharmacology/therapeutic use [MESH] |Apoptosis/*drug effects [MESH] |Cell Line, Tumor [MESH] |Cell Proliferation/drug effects [MESH] |Cell Survival/drug effects [MESH] |Cell-Penetrating Peptides/*pharmacology/therapeutic use [MESH] |Female [MESH] |Gene Expression Regulation, Neoplastic/*drug effects [MESH] |Humans [MESH] |Male [MESH] |Mice [MESH] |Neoplasms/*drug therapy/genetics [MESH] |Rats [MESH] |Recombinant Proteins/pharmacology/therapeutic use [MESH]Targeting ATF5 in Cancer (epmc).pdf DeepDyve Pubget Overpricing